Xiao Zupeng, Wu Hanyi, Chen Xin, Chen Xiaoli, Yu Rentao, Chen Aijun
Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Clin Cosmet Investig Dermatol. 2023 Dec 29;16:3767-3773. doi: 10.2147/CCID.S444766. eCollection 2023.
Herpes zoster ophthalmicus (HZO) causes trouble in patients' daily life and work. In severe cases, it may even lead to a decrease or loss of vision. To understand the demographic information and ocular symptoms of hospitalized patients with HZO, and to find potential factors related to improvement time of skin rash and duration of ocular symptoms at discharge, we design this study.
This is a retrospective study. All patients diagnosed with HZO who were hospitalized in the Department of Dermatology of a hospital in Chongqing, China from January 1, 2015 to December 30, 2021 were included in this study. A total of 189 patients were included in this study. Clinical manifestations of the disease during hospitalization, improvement time of ocular skin lesions, and whether ocular skin lesions disappeared completely at discharge were recorded.
The most common ocular symptom was eyelid swelling (92.6%), followed by eye pain (48.7%). The most common ocular sign was conjunctivitis (78.3%), followed by keratitis (15.9%). There were 149 cases without residual ocular symptoms and 40 cases with residual ocular symptoms. There was no statistically significant difference in demographic characteristics between the two groups (P>0.05). Age ≥70 years (B=0.381, -0.0610.022, P=0.005), use of glucocorticoids (B=0.260, 0.0240.496, P=0.031), and use of topical antiviral drugs (B=0.380, 0.0540.705, P=0.023) were factors affecting the time interval from admission to improvement of skin rash. Tearing (HR, OR=4.827, 1.95611.909, P<0.001) and blood urea nitrogen (OR=0.787, 0.620-1.000, P=0.050) were factors influencing residual ocular symptoms.
This study could help clinicians gain a deeper understanding of the clinical manifestations and partial influencing factors of HZO patients, which may contribute to future clinical work.
眼部带状疱疹(HZO)给患者的日常生活和工作带来困扰。严重时,甚至可能导致视力下降或丧失。为了解HZO住院患者的人口统计学信息和眼部症状,并找出与皮疹改善时间及出院时眼部症状持续时间相关的潜在因素,我们设计了本研究。
这是一项回顾性研究。纳入2015年1月1日至2021年12月30日在中国重庆某医院皮肤科住院的所有诊断为HZO的患者。本研究共纳入189例患者。记录住院期间疾病的临床表现、眼部皮肤病变的改善时间以及出院时眼部皮肤病变是否完全消失。
最常见的眼部症状是眼睑肿胀(92.6%),其次是眼痛(48.7%)。最常见的眼部体征是结膜炎(78.3%),其次是角膜炎(15.9%)。149例无残留眼部症状,40例有残留眼部症状。两组患者的人口统计学特征无统计学差异(P>0.05)。年龄≥70岁(B=0.381,-0.0610.022,P=0.005)、使用糖皮质激素(B=0.260,0.0240.496,P=0.031)以及使用局部抗病毒药物(B=0.380,0.0540.705,P=0.023)是影响从入院到皮疹改善时间间隔的因素。流泪(HR,OR=4.827,1.95611.909,P<0.001)和血尿素氮(OR=0.787,0.620-1.000,P=0.050)是影响残留眼部症状的因素。
本研究有助于临床医生更深入地了解HZO患者的临床表现和部分影响因素,可能对未来的临床工作有所帮助。